Stay updated with breaking news from Richard pencek. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Interim results from INTEGRIS-PSC to be featured in an oral presentation on Monday, November 13SOUTH SAN FRANCISCO, Calif., Oct. 19, 2023 Pliant Therapeutics, Inc. , a clinical-stage. ....
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Metacrine to Present Final Results from Phase 1 Trial of MET642, an Optimized FXR Agonist, at . Metacrine, Inc.March 11, 2021 GMT SAN DIEGO, March 11, 2021 (GLOBE NEWSWIRE) Metacrine, Inc. (Nasdaq: MTCR), a clinical-stage biopharmaceutical company focused on discovering and developing differentiated therapies for patients with liver and gastrointestinal diseases, today announced that final results from the company’s Phase 1 trial of MET642, a farnesoid X receptor (FXR) agonist in development for the treatment of non-alcoholic steatohepatitis (NASH), will be presented as a distinguished abstract at the 2021 NASH-TAG Conference. The conference is taking place March 11-13, 2021 in Park City, Utah and virtually on-line. ....